Find a Doctor or Practice Location

Are you a referring physician?
I am searching for a
Reset Form
Stephen J. Schuster, MD

Stephen J. Schuster, MD Physician

Director, Lymphoma Program Director, Lymphoma Translational Research Robert and Margarita Louis-Dreyfus Professor in Chronic Lymphocytic Leukemia and Lymphoma Clinical Care and Research Professor C-E Professor C-E

Dr. Schuster is employed by Penn Medicine.

About Dr. Stephen J. Schuster

Recognized by America's Top Doctors 2011 - 2018

Recognized by Best Doctors in America 2005 - 2006, 2011 - 2012, 2015 - 2018

Recognized in Philadelphia magazine's annual Top Docs issues, 2002, and 2010 - 2018

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Patient Comments

Clinical Specialties


  • Hematology
  • Medical Oncology

Programs & Centers:

Board Certification:

  • Hematology, 1986
  • Internal Medicine, 1984
  • Medical Oncology, 1989

Clinical Expertise:

  • Lymphoma

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: Jefferson Medical College
Residency: Pennsylvania Hospital
Fellowship: Thomas Jefferson University Hospital
Fellowship: Pennsylvania Hospital


American Society of Clinical Oncology, National American Society of Hematology, National Eastern Cooperative Oncology Group (ECOG), National Leukemia & Lymphoma Society, National

Hospital Affiliation

Dr. Schuster is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.


Selected Publications:

Mato, Anthony R. Nabhan, Chadi. Thompson, Chadi. Lamanna, Nicole. Brander, Danielle M. Hill, Brian. Howlett, Christina. Skarbnik, Alan. Cheson, Bruce D. Zent, Clive. Pu, Jeffrey. Kiselev, Pavel. Goy, Andre. Claxton, David. Isaack, Krista. Kennard, Kaitlin H. Timlin, Colleen. Landsburg, Daniel. Winter, Allison. Nasta, Sunita D. Bachow, Spencer H. Schuster, Stephen J. Dorsey, Colleen. Svoboda, Jakub. Barr, Paul. Ujjani, Chaitra S.: Toxicities and outcomes of 621 ibrutinib-treated chronic lymphocytic leukemia patients in the United States: a real-world analysis. Haematologica. : 2018.

Mato, Anthony R. Thompson, Meghan C. Nabhan, Chadi. Svoboda, Jakub. Schuster, Stephen J.: Chimeric Antigen Receptor T-Cell Therapy for Chronic Lymphocytic Leukemia: A Narrative Review. Clinical Lymphoma Myeloma and Leukemia. 17 (12): 852-856,2017.

Schuster, Stephen J. Svoboda, Jakub. Chong, Elise A. Nasta, Sunita D. Mato, Anthony R. Anak, Özlem. Brogdon, Jennifer L. Pruteanu-Malinici, Iulian. Bhoj, Vijay. Landsburg, Daniel. Wasik, Mariusz. Levine, Bruce L. Lacey, Simon F. Melenhorst, Jan J. Porter, David L. June, Carl H.: Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas. the New England Journal of Medicine. : 2017.

Wang, Michael. Schuster, Stephen J. Phillips, Tycel. Lossos, Izidore S. Goy, Andre. Rule, Simon. Hamadani, Mehdi. Ghosh, Nilanjan. Reeder, Craig B. Barnett, Evelyn. Casadebaig Bravo, Marie-Laure. Martin, Peter.: Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004). Journal of Hematology Oncology. 10 (1): 171,2017.

Bair, Steven M. Strelec, Lauren. Nagle, Sarah J. Nasta, Sunita D. Landsburg, Daniel J. Mato, Anthony R. Loren, Alison W. Schuster, Stephen J. Stadtmauer, Edward A. Svoboda, Jakub.: Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis. American Journal of Hematology. 92 (9): 879-884,2017.

Jones, Jeffrey A. Hillmen, Peter. Coutre, Steven. Tam, Constantine. Furman, Richard R. Barr, Paul M. Schuster, Stephen J. Kipps, Thomas J. Flinn, Ian W. Jaeger, Ulrich. Burger, Jan A. Cheng, Mei. Ninomoto, Joi. James, Danelle F. Byrd, John C. O'Brien, Susan M.: Use of anticoagulants and antiplatelet in patients with chronic lymphocytic leukaemia treated with single-agent ibrutinib. British Journal of Haematology. 178 (2): 286-291,2017.

Kremer, Brandon. Tsai, Donald E. Debonera, Fotini. Cohen, Patti L. Schuster, Stephen J.: Spontaneous remission of acute myeloid leukemia after discontinuation of lenalidomide. Leukemia & Lymphoma. : 2017.

Salles, Gilles. Schuster, Stephen J. de Vos, Sven. Wagner-Johnston, Nina D. Viardot, Andreas. Blum, Kristie A. Flowers, Christopher R. Jurczak, Wojciech J. Flinn, Ian W. Kahl, Brad S. Martin, Peter. Kim, Yeonhee. Shreay, Sanatan. Will, Matthias. Sorensen, Bess. Breuleux, Madlaina. Zinzani, Pier Luigi. Gopal, Ajay K.: Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study. Haematologica. 102 (4): 2017.

Mato, Anthony R. Timlin, Colleen. Ujjani, Chaitra. Skarbnik, Alan. Howlett, Christina. Banerjee, Rahul. Nabhan, Chadi. Schuster, Stephen J.: Comparable outcomes in chronic lymphocytic leukaemia (CLL) patients treated with reduced-dose ibrutinib: results from a multi-centre study. British Journal of Haematology. : 2017.

Chong, Elise A. Melenhorst, J Joseph. Lacey, Simon F. Ambrose, David E. Gonzalez, Vanessa. Levine, Bruce. June, Carl H. Schuster, Stephen J.: PD-1 Blockade Modulates Chimeric Antigen Receptor (CAR) Modified T Cells and Induces Tumor Regression: Refueling the CAR. Blood. 129 (8): 2017.

Academic Contact Info

Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-157
3400 Civic Center Blvd

Philadelphia, PA 19104
Phone: (215) 614-1846
Patient appointments: 800-789-7366 (PENN)

Related Links